Treatment of murine CD5- B cells with anti-lg, but not LPS, induces surface CD5: Two B-cell activation pathways

Cong Ying-zl, Evelyn Rabin, Henry H. Wortis

Research output: Contribution to journalArticlepeer-review

237 Scopus citations


Antl-lg stimulated murine B cells express high levels of surface CD5 (ly-1) and increased CD44 while maintaining surface IgD, CD23 and J11d. Sorting of CD5- and CD5+ cells demonstrates that anti-lg induces CD5 expression rather than the selective expansion of CD5+ cells. Anti Ig plus interieukln-6 (IL-6) induces the CD23, IgD, low ly-5 (B220) (CD45low), J11dhigh phenotype of typical CD5+ peritoneal B cells. In contrast, lipopolysaccharide (LPS)-stimulated B cells have high levels of CD44 but decreased surface IgD, CD23 and J11d and no CD5. Thus LPS and anti-lg generate activated cells with differing phenotypes. Induced CD5+ cells have increased viability, even in the absence of added exogenous factors, while the viability of CD5- B cells is dependent on factors such as IL-4. We conclude that conventional CD5- B cellscan be activated by either of two pathways: one generating CD5+ B cells; the other yielding conventional activated cells. We hypothesize that the first path requires slg cross-linking and corresponds to T-independent (type 2) stimulation, while cognate Interaction with helper T cells in the absence of slg cross-linking induces B cells to enter the second path.

Original languageEnglish (US)
Pages (from-to)467-476
Number of pages10
JournalInternational immunology
Issue number5
StatePublished - May 1991
Externally publishedYes


  • CD23
  • CD44
  • CD45
  • IL-4
  • IL-6
  • J11d
  • LgD
  • Ly-1
  • Ly-5
  • Lymphocytes
  • Pgp-1
  • Thymu-dependent antigent
  • Thymus-dependent antigent

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Treatment of murine CD5- B cells with anti-lg, but not LPS, induces surface CD5: Two B-cell activation pathways'. Together they form a unique fingerprint.

Cite this